Cargando…

Publisher Correction: The janus-kinase inhibitor ruxolitinib in SARS-CoV-2 induced acute respiratory distress syndrome (ARDS)

Detalles Bibliográficos
Autores principales:	Neubauer, Andreas, Johow, Johannes, Mack, Elisabeth, Burchert, Andreas, Meyn, Damaris, Kadlubiec, Andrea, Torje, Iuliu, Wulf, Hinnerk, Vogelmeier, Claus F., Hoyer, Joachim, Skevaki, Chrysanthi, Muellenbach, Ralf Michael, Keller, Christian, Schade-Brittinger, Carmen, Rolfes, Caroline, Wiesmann, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436193/ https://www.ncbi.nlm.nih.gov/pubmed/34518646 http://dx.doi.org/10.1038/s41375-021-01412-0

Ejemplares similares

The janus-kinase inhibitor ruxolitinib in SARS-CoV-2 induced acute respiratory distress syndrome (ARDS)
por: Neubauer, Andreas, et al.
Publicado: (2021)

Ruxolitinib for the treatment of SARS-CoV-2 induced acute respiratory distress syndrome (ARDS)
por: Neubauer, Andreas, et al.
Publicado: (2020)

Serum proteomics hint at an early T-cell response and modulation of SARS-CoV-2-related pathogenic pathways in COVID-19-ARDS treated with Ruxolitinib
por: Völkel, Sara, et al.
Publicado: (2023)

The Benefit of Benzodiazepine Reduction: Improving Sedation in Surgical Intensive Care
por: Schneider, Ralph, et al.
Publicado: (2017)

The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19
por: Gozzetti, Alessandro, et al.
Publicado: (2020)

Protocol for an observational study to identify potential predictors of an acute exacerbation in patients with chronic obstructive pulmonary disease (the PACE Study)
por: Kenn, Klaus, et al.
Publicado: (2021)

Aggressive squamous cell carcinoma in a patient on the Janus kinase inhibitor ruxolitinib
por: Aboul-Fettouh, Nader, et al.
Publicado: (2018)

MANIFEST: Pelabresib in Combination With Ruxolitinib for Janus Kinase Inhibitor Treatment-Naïve Myelofibrosis
por: Mascarenhas, John, et al.
Publicado: (2023)

The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation
por: La Rosée, F., et al.
Publicado: (2020)

Severe ARDS due to Ruxolitinib discontinuation syndrome: case presentation and literature review
por: Houthuys, Jona F., et al.
Publicado: (2022)

Mechanical ventilation in early COVID-19 ARDS
por: Lepper, Philipp M., et al.
Publicado: (2020)

Recommendations for anesthesia and perioperative management in patients with Ehlers-Danlos syndrome(s)
por: Wiesmann, Thomas, et al.
Publicado: (2014)

Extracorporeal liver support: trending epidemiology and mortality - a nationwide database analysis 2007–2015
por: Wiesmann, Thomas, et al.
Publicado: (2019)

Efficacy of a Low-threshold, Culturally-Sensitive Group Psychoeducation Programme for Asylum Seekers (LoPe): study protocol for a multicentre randomised controlled trial
por: Weise, Cornelia, et al.
Publicado: (2021)

The Janus Kinase Inhibitor Ruxolitinib Prevents Terminal Shock in a Mouse Model of Arenavirus Hemorrhagic Fever
por: Sahin, Mehmet, et al.
Publicado: (2021)

Could ruxolitinib be effective in patients with COVID-19 infection at risk of acute respiratory distress syndrome (ARDS)?
por: Caocci, Giovanni, et al.
Publicado: (2020)

Effect of bupivacaine and adjuvant drugs for regional anesthesia on nerve tissue oximetry and nerve blood flow
por: Wiesmann, Thomas, et al.
Publicado: (2018)

Effect of bupivacaine and adjuvant drugs on skeletal muscle tissue oximetry and blood flow: an experimental study
por: Schubert, Ann-Kristin, et al.
Publicado: (2019)

Perioperative Schmerztherapie bei minimal-invasiver Thoraxchirurgie
por: Bach, Katharina, et al.
Publicado: (2023)

Ruxolitinib suppresses liver fibrosis progression and accelerates fibrosis reversal via selectively targeting Janus kinase 1/2
por: Song, Zhenghui, et al.
Publicado: (2022)

Various Application of Tofacitinib and Ruxolitinib (Janus Kinase Inhibitors) in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective
por: Sadeghi, Sara, et al.
Publicado: (2022)

Viral load-guided immunosuppression after lung transplantation (VIGILung)—study protocol for a randomized controlled trial
por: Gottlieb, Jens, et al.
Publicado: (2021)

Supplemental Interscalene Blockade to General Anesthesia for Shoulder Arthroscopy: Effects on Fast Track Capability, Analgesic Quality, and Lung Function
por: Zoremba, Martin, et al.
Publicado: (2015)

Long-term Effects of the Janus Kinase 1/2 Inhibitor Ruxolitinib on Pulmonary Hypertension and the Cardiac Function in a Patient with Myelofibrosis
por: Miyawaki, Hiroshi, et al.
Publicado: (2019)

Unexpected Hair Regrowth in a Patient with Longstanding Alopecia Universalis During Treatment of Recalcitrant Dermatomyositis with the Janus Kinase Inhibitor Ruxolitinib
por: FETTER, Tanja, et al.
Publicado: (2020)

Activation of Group 2 Innate Lymphoid Cells via TL1A/DR3. A Solution to Corticosteroid Resistance?
por: Skevaki, Chrysanthi, et al.
Publicado: (2020)

The opposite impact of Janus kinase inhibitor Ruxolitinib on the function of bone marrow mesenchymal stem cells and immune cells in acute GVHD recipients
por: Zeng, Defu
Publicado: (2023)

Thermotaxis of Janus particles
por: Auschra, Sven, et al.
Publicado: (2021)

Chlorhexidine Gluconate Dressings Reduce Bacterial Colonization Rates in Epidural and Peripheral Regional Catheters
por: Kerwat, Klaus, et al.
Publicado: (2015)

Programmed intermittent epidural bolus versus continuous epidural infusion for postoperative analgesia after major abdominal and gynecological cancer surgery: a randomized, triple-blinded clinical trial
por: Wiesmann, Thomas, et al.
Publicado: (2018)

Recovery and prediction of postoperative muscle power – is it still a problem?
por: Zoremba, Martin, et al.
Publicado: (2017)

Editorial: Early Life Origins of Immune-Mediated Disease
por: Skevaki, Chrysanthi, et al.
Publicado: (2020)

Antibody repertoire and autoimmunity
por: Skevaki, Chrysanthi, et al.
Publicado: (2023)

Ruxolitinib for myelofibrosis
por: GU, LIAN, et al.
Publicado: (2013)

Mechanical Ventilation during Extracorporal Support: The Relevance of Vt
por: Kredel, Markus, et al.
Publicado: (2019)

Janus kinase inhibitor ruxolitinib in combination with nilotinib and prednisone in patients with myelofibrosis (RuNiC study): A phase Ib, multicenter study
por: Ayala, Rosa, et al.
Publicado: (2023)

Videolaryngoscopy versus direct laryngoscopy for double-lumen endotracheal tube intubation in thoracic surgery - a randomised controlled clinical trial
por: Risse, Joachim, et al.
Publicado: (2020)

Respiratory virus-induced heterologous immunity: Part of the problem or part of the solution?
por: Pusch, Emanuel, et al.
Publicado: (2018)

Respiratory virus-induced heterologous immunity: Part of the problem or part of the solution?
por: Pusch, Emanuel, et al.
Publicado: (2018)

Ruxolitinib: Thrombocytopenia following compassionate use of ruxolitinib: 2 case reports
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v385772b2hkr2igoqvg83m4058